Spots Global Cancer Trial Database for hypofractionated radiation therapy
Every month we try and update this database with for hypofractionated radiation therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies | NCT04068194 | Cholangiocarcin... Gallbladder Car... Stage III Gallb... Stage III Hilar... Stage III Intra... Stage IV Gallbl... Stage IV Hilar ... Stage IV Intrah... | Avelumab Biopsy Biospecimen Col... Computed Tomogr... Hypofractionate... Peposertib | 18 Years - | National Cancer Institute (NCI) | |
| Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer | NCT01266642 | Ductal Breast C... Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... | External Beam R... External Beam R... Hypofractionate... Laboratory Biom... Quality-of-Life... Questionnaire A... Whole Breast Ir... Whole Breast Ir... | 40 Years - | M.D. Anderson Cancer Center | |
| Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer | NCT03796767 | Recurrent Prost... Metastatic Mali... Metastatic Mali... Oligometastasis Prostate Adenoc... PSA Failure | Hypofractionate... Intensity-Modul... Metastasectomy Quality-of-Life... Questionnaire A... Stereotactic Bo... | 18 Years - | University of Utah | |
| Retifanlimab With Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma | NCT06160206 | Recurrent Gliob... Recurrent WHO G... | Bevacizumab Biospecimen Col... Computed Tomogr... Electronic Heal... Hypofractionate... Magnetic Resona... Retifanlimab | 18 Years - | Academic and Community Cancer Research United | |
| Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer. ICORG 99-09 | NCT00955175 | Lung Cancer | hypofractionate... | - 120 Years | Cancer Trials Ireland | |
| SMC Radiation Oncology Breast Cancer Cohort Study | NCT05775757 | Radiotherapy Si... | Hypofractionate... | 18 Years - 85 Years | Samsung Medical Center | |
| Trial of Hypofractionated Radiation Therapy for Glioblastoma | NCT02206230 | Glioblastoma | Hypofractionate... Standard radiat... | 18 Years - 70 Years | AHS Cancer Control Alberta | |
| Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer | NCT03419130 | Infiltrating Bl... Stage II Bladde... Stage III Bladd... | Hypofractionate... Laboratory Biom... Pembrolizumab Radiation Thera... | 18 Years - | University of California, San Francisco | |
| Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT01345851 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | hypofractionate... laboratory biom... image-guided ra... carboplatin paclitaxel stereotactic bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients | NCT04310020 | Recurrent Lung ... Stage II Lung C... Stage III Lung ... Unresectable Lu... | Atezolizumab Biospecimen Col... Computed Tomogr... Hypofractionate... Magnetic Resona... | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma | NCT00822848 | Sarcoma | epirubicin hydr... ifosfamide sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... adjuvant therap... neoadjuvant the... therapeutic con... hypofractionate... | 15 Years - 120 Years | OHSU Knight Cancer Institute | |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | NCT00550654 | Kidney Cancer Melanoma (Skin) Metastatic Canc... Ovarian Cancer Sarcoma Unspecified Adu... | questionnaire a... 3-dimensional c... hypofractionate... image-guided ra... tomotherapy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall | NCT02634710 | Soft Tissue Sar... | Hypofractionate... | 18 Years - | Medical College of Wisconsin | |
| Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer | NCT03345420 | Ductal Breast C... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... | Hypofractionate... | 18 Years - | University of Utah | |
| Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma | NCT04708067 | Locally Advance... Metastatic Intr... Stage III Intra... Stage IIIA Intr... Stage IIIB Intr... Stage IV Intrah... | Bintrafusp Alfa Biopsy Hypofractionate... | 18 Years - | M.D. Anderson Cancer Center | |
| Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer | NCT00852644 | Lung Cancer | computed tomogr... fludeoxyglucose... hypofractionate... stereotactic ra... | 18 Years - | Boston Medical Center | |
| Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery | NCT02262325 | Recurrent Non-s... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | hypofractionate... cisplatin etoposide 3-dimensional c... laboratory biom... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status | NCT00986297 | Lung Cancer | hypofractionate... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial | NCT05161533 | Extensive Stage... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ... | Carboplatin Cisplatin Durvalumab Etoposide Hypofractionate... Quality-of-Life... Questionnaire A... | 18 Years - | University of Washington | |
| ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy | NCT04372927 | Locally Advance... Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... | Cisplatin Durvalumab Etoposide Hypofractionate... Pemetrexed | 18 Years - | University of Washington | |
| Radiation Therapy Before Surgery for Localized, Resectable Soft Tissue Sarcoma of the Extremity and Superficial Trunk | NCT04562480 | Resectable Soft... Stage I Soft Ti... Stage IA Soft T... Stage IB Soft T... Stage II Soft T... | Hypofractionate... Quality-of-Life... Questionnaire A... Resection | 18 Years - | Mayo Clinic | |
| Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer | NCT00852644 | Lung Cancer | computed tomogr... fludeoxyglucose... hypofractionate... stereotactic ra... | 18 Years - | Boston Medical Center | |
| Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer | NCT03050060 | Metastatic Kidn... Recurrent Lung ... Stage IV Cutane... Stage IV Renal ... Stage IV Lung N... | Atezolizumab Hypofractionate... Laboratory Biom... Nelfinavir Mesy... Nivolumab Pembrolizumab | 18 Years - | University of Washington | |
| Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer | NCT00872625 | Breast Cancer | cyclophosphamid... docetaxel epirubicin hydr... fluorouracil neoadjuvant the... therapeutic con... hypofractionate... image-guided ra... radiation thera... stereotactic ra... | 18 Years - | Centre Antoine Lacassagne | |
| Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery | NCT02262325 | Recurrent Non-s... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | hypofractionate... cisplatin etoposide 3-dimensional c... laboratory biom... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Shorter Course, Hypofractionated Pre-Surgery Radiation Therapy in Treating Patients With Localized, Resectable Soft Tissue Sarcoma of the Extremity of Superficial Trunk | NCT03819985 | Resectable Soft... Stage I Soft Ti... Stage IA Soft T... Stage IB Soft T... Stage II Soft T... Stage III Soft ... Stage IIIA Soft... Stage IIIB Soft... | Hypofractionate... Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Intraoperative Boost Radiotherapy With Electrons (IOERT) Followed By Hypofractionated Whole-Breast Irradiation (WBRT) | NCT01295723 | Invasive Lobula... | Hypofractionate... Intraoperative ... | 40 Years - | St. Joseph Hospital of Orange | |
| Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC) | NCT05784142 | Lung Cancer, No... | hypofractionate... | 18 Years - | Jiangsu Cancer Institute & Hospital | |
| Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer | NCT03345420 | Ductal Breast C... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... | Hypofractionate... | 18 Years - | University of Utah | |
| Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer | NCT00946543 | Prostate Cancer | hypofractionate... intensity-modul... | - | National Cancer Institute (NCI) | |
| Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer | NCT00714753 | Prostate Cancer | brachytherapy hypofractionate... image-guided ra... intensity-modul... | 18 Years - 120 Years | Mayo Clinic | |
| Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial | NCT04624256 | Prostate Adenoc... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... | Discussion Hypofractionate... Hypofractionate... Laboratory Biom... Quality-of-Life... Questionnaire A... Stereotactic Bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer | NCT03419130 | Infiltrating Bl... Stage II Bladde... Stage III Bladd... | Hypofractionate... Laboratory Biom... Pembrolizumab Radiation Thera... | 18 Years - | University of California, San Francisco | |
| A Study to Evaluate Pre- or Post-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa. | NCT06022159 | Soft Tissue Sar... | Patients will r... Patient will un... | 65 Years - | Institut Claudius Regaud | |
| A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms | NCT02163226 | Bone Metastases | Hypofractionate... One Radiation T... Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients | NCT04398199 | Nonsmall Cell L... Nonsmall Cell L... | Hypofractionate... Radiation Boost | 18 Years - | Wake Forest University Health Sciences | |
| Retifanlimab With Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma | NCT06160206 | Recurrent Gliob... Recurrent WHO G... | Bevacizumab Biospecimen Col... Computed Tomogr... Electronic Heal... Hypofractionate... Magnetic Resona... Retifanlimab | 18 Years - | Academic and Community Cancer Research United | |
| Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients | NCT04398199 | Nonsmall Cell L... Nonsmall Cell L... | Hypofractionate... Radiation Boost | 18 Years - | Wake Forest University Health Sciences | |
| Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma | NCT04708067 | Locally Advance... Metastatic Intr... Stage III Intra... Stage IIIA Intr... Stage IIIB Intr... Stage IV Intrah... | Bintrafusp Alfa Biopsy Hypofractionate... | 18 Years - | M.D. Anderson Cancer Center | |
| Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity | NCT02295540 | Stage III Squam... Stage III Verru... Stage IVA Squam... Stage IVA Verru... Stage IVB Squam... Stage IVB Verru... Tongue Cancer | hypofractionate... intensity-modul... therapeutic con... laboratory biom... | 18 Years - | Rutgers, The State University of New Jersey | |
| Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status | NCT00986297 | Lung Cancer | hypofractionate... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial | NCT01138722 | Early Stage Non... | hypofractionate... | 18 Years - | University Hospital, Ghent | |
| LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138) | NCT04699773 | Glioma Glioblastoma Brain Tumor | LITT Hypofractionate... | 18 Years - | University of Maryland, Baltimore | |
| Hypofractionated Radiation Therapy for Glioblastoma | NCT03212235 | Glioblastoma Mu... | Hypofractionate... | 18 Years - 70 Years | Instituto do Cancer do Estado de São Paulo | |
| Radiation Therapy in Treating Women Undergoing Lumpectomy for Stage I or Stage IIA Breast Cancer | NCT00602108 | Breast Cancer | adjuvant therap... conventional su... hypofractionate... intraoperative ... | 21 Years - | Mayo Clinic | |
| Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER) | NCT04106856 | Borderline Rese... Locally Advance... Locally Advance... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | Hypofractionate... Losartan Losartan Potass... Quality-of-Life... Questionnaire A... | 18 Years - | University of Utah | |
| Radiation Therapy Before Surgery for Localized, Resectable Soft Tissue Sarcoma of the Extremity and Superficial Trunk | NCT04562480 | Resectable Soft... Stage I Soft Ti... Stage IA Soft T... Stage IB Soft T... Stage II Soft T... | Hypofractionate... Quality-of-Life... Questionnaire A... Resection | 18 Years - | Mayo Clinic | |
| Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer | NCT00425841 | Pancreatic Canc... | gemcitabine hyd... oxaliplatin adjuvant therap... neoadjuvant the... hypofractionate... stereotactic ra... | 18 Years - | Technical University of Munich | |
| Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to Radiation Therapy for Localized Pancreatic Cancer | NCT04172532 | Locally Advance... Locally Advance... Stage II Pancre... Stage III Pancr... Unresectable Pa... | Biopsy Biospecimen Col... Computed Tomogr... Hypofractionate... Magnetic Resona... Peposertib Placebo Adminis... | 18 Years - | National Cancer Institute (NCI) | |
| Trial of Hypofractionated Radiation Therapy for Glioblastoma | NCT02206230 | Glioblastoma | Hypofractionate... Standard radiat... | 18 Years - 70 Years | AHS Cancer Control Alberta | |
| Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation | NCT06110572 | Extensive Stage... Stage IV Lung C... | Carboplatin Atezolizumab Etoposide Total Body Irra... Hypofractionate... Magnetic Resona... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial | NCT05161533 | Extensive Stage... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ... | Carboplatin Cisplatin Durvalumab Etoposide Hypofractionate... Quality-of-Life... Questionnaire A... | 18 Years - | University of Washington | |
| Trial of Hypofractionated Radiation Therapy for Glioblastoma | NCT02206230 | Glioblastoma | Hypofractionate... Standard radiat... | 18 Years - 70 Years | AHS Cancer Control Alberta | |
| Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer | NCT03414970 | Ductal Breast C... Invasive Breast... Lobular Breast ... Medullary Breas... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Tubular Breast ... | Radiation Thera... Questionnaire A... Quality-of-Life... Laboratory Biom... Hypofractionate... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy | NCT03570827 | Prostate Adenoc... Stage IIB Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... | Androgen Suppre... Hypofractionate... Quality-of-Life... Questionnaire A... | 18 Years - | Mayo Clinic | |
| Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer | NCT02701400 | Recurrent Small... | Durvalumab Hypofractionate... Stereotactic Bo... Tremelimumab | 18 Years - | Emory University | |
| Hypofractionated Radiation Therapy in Patients With Breast Cancer | NCT04075058 | Breast Cancer | Hypofractionate... | 18 Years - 80 Years | PGIMER | |
| Hypofractionated Radiation Therapy in Patients With Breast Cancer | NCT04075058 | Breast Cancer | Hypofractionate... | 18 Years - 80 Years | PGIMER | |
| Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer | NCT00872625 | Breast Cancer | cyclophosphamid... docetaxel epirubicin hydr... fluorouracil neoadjuvant the... therapeutic con... hypofractionate... image-guided ra... radiation thera... stereotactic ra... | 18 Years - | Centre Antoine Lacassagne | |
| Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma | NCT04708067 | Locally Advance... Metastatic Intr... Stage III Intra... Stage IIIA Intr... Stage IIIB Intr... Stage IV Intrah... | Bintrafusp Alfa Biopsy Hypofractionate... | 18 Years - | M.D. Anderson Cancer Center | |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | NCT00550654 | Kidney Cancer Melanoma (Skin) Metastatic Canc... Ovarian Cancer Sarcoma Unspecified Adu... | questionnaire a... 3-dimensional c... hypofractionate... image-guided ra... tomotherapy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer | NCT00946543 | Prostate Cancer | hypofractionate... intensity-modul... | - | National Cancer Institute (NCI) | |
| Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT01345851 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | hypofractionate... laboratory biom... image-guided ra... carboplatin paclitaxel stereotactic bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma | NCT06078709 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... | Biospecimen Col... Computed Tomogr... Endoscopic Ultr... Esophagogastrod... Fluorouracil Hypofractionate... Leucovorin Calc... Oxaliplatin Positron Emissi... Survey Administ... | 18 Years - | Mayo Clinic | |
| Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas | NCT01478321 | Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... | Temozolomide hypofractionate... bevacizumab questionnaire a... | 18 Years - | Northwestern University | |
| Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity | NCT02295540 | Stage III Squam... Stage III Verru... Stage IVA Squam... Stage IVA Verru... Stage IVB Squam... Stage IVB Verru... Tongue Cancer | hypofractionate... intensity-modul... therapeutic con... laboratory biom... | 18 Years - | Rutgers, The State University of New Jersey | |
| Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery | NCT02262325 | Recurrent Non-s... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | hypofractionate... cisplatin etoposide 3-dimensional c... laboratory biom... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer | NCT00852644 | Lung Cancer | computed tomogr... fludeoxyglucose... hypofractionate... stereotactic ra... | 18 Years - | Boston Medical Center | |
| Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers | NCT01138748 | Inoperable Earl... | hypofractionate... | 18 Years - | University Hospital, Ghent | |
| Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation | NCT02958774 | Breast Cancer | Hypofractionate... | 18 Years - | University of Kansas Medical Center | |
| Hypofractionated Radiotherapy Followed by Durvalumab With or Without Tremelimumab for Liver Cancer After Progression on PD-1 Inhibition | NCT04430452 | Advanced Hepato... Stage III Hepat... Stage IIIA Hepa... Stage IIIB Hepa... Stage IV Hepato... Stage IVA Hepat... Stage IVB Hepat... | Durvalumab Hypofractionate... Tremelimumab | 18 Years - | University of California, San Francisco | |
| Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer | NCT01068327 | Adenocarcinoma ... Stage III Pancr... | gemcitabine hyd... leucovorin calc... fluorouracil nelfinavir mesy... stereotactic bo... hypofractionate... therapeutic con... | 19 Years - | University of Nebraska | |
| Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma | NCT04318717 | Mucosal Melanom... | Pembrolizumab Hypofractionate... | 16 Years - | Washington University School of Medicine | |
| Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial | NCT01138722 | Early Stage Non... | hypofractionate... | 18 Years - | University Hospital, Ghent | |
| Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer | NCT03796767 | Recurrent Prost... Metastatic Mali... Metastatic Mali... Oligometastasis Prostate Adenoc... PSA Failure | Hypofractionate... Intensity-Modul... Metastasectomy Quality-of-Life... Questionnaire A... Stereotactic Bo... | 18 Years - | University of Utah | |
| Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery | NCT03624478 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... | Hypofractionate... | 18 Years - | Mayo Clinic |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
